Cargando…

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

Detalles Bibliográficos
Autores principales: Merighi, Stefania, Poloni, Tino Emanuele, Pelloni, Lucia, Pasquini, Silvia, Varani, Katia, Vincenzi, Fabrizio, Borea, Pier Andrea, Gessi, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019913/
https://www.ncbi.nlm.nih.gov/pubmed/33828485
http://dx.doi.org/10.3389/fphar.2021.652455
_version_ 1783674475850498048
author Merighi, Stefania
Poloni, Tino Emanuele
Pelloni, Lucia
Pasquini, Silvia
Varani, Katia
Vincenzi, Fabrizio
Borea, Pier Andrea
Gessi, Stefania
author_facet Merighi, Stefania
Poloni, Tino Emanuele
Pelloni, Lucia
Pasquini, Silvia
Varani, Katia
Vincenzi, Fabrizio
Borea, Pier Andrea
Gessi, Stefania
author_sort Merighi, Stefania
collection PubMed
description
format Online
Article
Text
id pubmed-8019913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80199132021-04-06 An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment? Merighi, Stefania Poloni, Tino Emanuele Pelloni, Lucia Pasquini, Silvia Varani, Katia Vincenzi, Fabrizio Borea, Pier Andrea Gessi, Stefania Front Pharmacol Pharmacology Frontiers Media S.A. 2021-03-22 /pmc/articles/PMC8019913/ /pubmed/33828485 http://dx.doi.org/10.3389/fphar.2021.652455 Text en Copyright © 2021 Merighi, Poloni, Pelloni, Pasquini, Varani, Vincenzi, Borea and Gessi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Merighi, Stefania
Poloni, Tino Emanuele
Pelloni, Lucia
Pasquini, Silvia
Varani, Katia
Vincenzi, Fabrizio
Borea, Pier Andrea
Gessi, Stefania
An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title_full An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title_fullStr An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title_full_unstemmed An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title_short An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
title_sort open question: is the a(2a) adenosine receptor a novel target for alzheimer’s disease treatment?
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019913/
https://www.ncbi.nlm.nih.gov/pubmed/33828485
http://dx.doi.org/10.3389/fphar.2021.652455
work_keys_str_mv AT merighistefania anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT polonitinoemanuele anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT pellonilucia anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT pasquinisilvia anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT varanikatia anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT vincenzifabrizio anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT boreapierandrea anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT gessistefania anopenquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT merighistefania openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT polonitinoemanuele openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT pellonilucia openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT pasquinisilvia openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT varanikatia openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT vincenzifabrizio openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT boreapierandrea openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment
AT gessistefania openquestionisthea2aadenosinereceptoranoveltargetforalzheimersdiseasetreatment